Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 1113 - 1120 of 12038 results

Senator's Hold on FTC Nominee Robs Agency of Political Diversity, Regulatory Attorneys Say

January 29, 2024| News

OCR Releases Long Awaited Final Rule Regarding the Conscience Protections for Religious and Moral Objections in Health Care

January 29, 2024| Blog| Viewpoint

NERC Submits Work Plan for New Reliability Requirements to Apply to Inverter-Based Resources

January 26, 2024| Article| Viewpoint

What You Need to Know About FDA's Proposed Regulation of LDTs

January 26, 2024| News

Corporations with 10 or More ISO or ESPP Reporting Obligations on Forms 3921 or 3922 Should Take Notice of Revised Electronic Filing Requirements

January 25, 2024| Blog| Viewpoint

The DOL Issues a Final Rule Returning the Independent Contractor Classification Analysis under the FLSA to a More Employee-Friendly Test, Forcing Employers to Think Critically About Their Use of Independent Contractors in the Workplace

January 25, 2024| Blog| Viewpoint

ITC Blocks Imports Of TVs For Infringing AMD Patent

January 25, 2024| News

Health Care Privacy and Security in 2024: Six Critical Topics to Watch

January 25, 2024| Blog| Viewpoint

News & Press Releases

Amenities Draw Law Firm Mintz’s S.F. Office to 525 Market St.

July 15, 2025

San Francisco Business Times featured Mintz’s new office lease in San Francisco at 525 Market St. The firm will be increasing its footprint in downtown by 50% to 29,000 square feet on a whole single floor with the new space.

Mintz Advises on Cogent Biosciences’ $230 Million Public Offering

July 14, 2025

Mintz advised the underwriters in connection with a $230 million public offering by Cogent Biosciences, Inc. of 25,555,556 shares of common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses.

Mintz Advises on Soleno Therapeutics’ $200 Million Public Offering

July 14, 2025

Mintz advised the underwriters in connection with a $200 million public offering by Soleno Therapeutics, Inc. of 2,352,941 shares of its common stock at a price to the public of $85.00 per share. The gross proceeds to Soleno from the offering were approximately $200 million before deducting underwriting discounts and commissions and other offering expenses. In addition, Soleno granted the underwriters a 30-day option to purchase up to an additional 352,941 shares of its common stock at the public offering price.

View all News and Press Releases